Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19.
作者信息
Fang Xiaowei, Mei Qing, Yang Tianjun, Li Lei, Wang Yinzhong, Tong Fei, Geng Shike, Pan Aijun
机构信息
Department of Intensive Care Unit, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui Province 230001, China.
Department of Infectious Disease, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui Province 230001, China.
出版信息
J Infect. 2020 Jul;81(1):147-178. doi: 10.1016/j.jinf.2020.03.039. Epub 2020 Apr 11.
Abstract
摘要
相似文献
1
Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19.低剂量皮质类固醇疗法不会延迟新冠病毒疾病患者的病毒清除。
J Infect. 2020 Jul;81(1):147-178. doi: 10.1016/j.jinf.2020.03.039. Epub 2020 Apr 11.
2
Re: Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19.关于：低剂量皮质类固醇疗法不会延迟COVID-19患者的病毒清除
J Infect. 2020 Aug;81(2):e79-e81. doi: 10.1016/j.jinf.2020.05.004. Epub 2020 May 8.
3
Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19.在部分与新型冠状病毒肺炎相关的严重急性呼吸窘迫综合征患者中使用皮质类固醇。
J Infect. 2020 Aug;81(2):e89-e90. doi: 10.1016/j.jinf.2020.05.023. Epub 2020 May 14.
4
Contrasting evidence for corticosteroid treatment for coronavirus-induced cytokine storm.关于皮质类固醇治疗冠状病毒诱导的细胞因子风暴的对比证据。
Hong Kong Med J. 2020 Jun;26(3):269-271. doi: 10.12809/hkmj208517. Epub 2020 Jun 5.
5
Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.严重急性呼吸综合征冠状病毒 2 感染患者长期病毒排出的临床特征及相关因素：一项单中心 28 天研究。
J Infect Dis. 2020 Aug 17;222(6):910-918. doi: 10.1093/infdis/jiaa388.
6
Corticosteroid use for 2019-nCoV infection: A double-edged sword.2019新型冠状病毒感染中使用皮质类固醇：一把双刃剑。
Infect Control Hosp Epidemiol. 2020 Oct;41(10):1244-1245. doi: 10.1017/ice.2020.165. Epub 2020 Apr 23.
7
Corticosteroid Injections and COVID-19 Infection Risk.皮质类固醇注射与新冠病毒感染风险
Pain Med. 2020 Aug 1;21(8):1703-1706. doi: 10.1093/pm/pnaa199.
8
Pain Management Best Practices from Multispecialty Organizations During the COVID-19 Pandemic and Public Health Crises-Evaluating the Risk of Infection Associated with Corticosteroid Injections.新冠疫情和公共卫生危机期间多专科组织的疼痛管理最佳实践——评估皮质类固醇注射相关的感染风险
Pain Med. 2020 Aug 1;21(8):1730-1731. doi: 10.1093/pm/pnaa167.
9
The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19.皮质类固醇疗法降低重症 COVID-19 死亡率的十个原因。
Intensive Care Med. 2020 Nov;46(11):2067-2070. doi: 10.1007/s00134-020-06223-y. Epub 2020 Oct 7.
10
Pros and cons of corticosteroid therapy for COVID-19 patients.COVID-19 患者使用皮质类固醇治疗的利弊。
Respir Physiol Neurobiol. 2020 Sep;280:103492. doi: 10.1016/j.resp.2020.103492. Epub 2020 Jul 10.
引用本文的文献
1
Should the Start of Immunosuppressive Treatment for COVID-19 Rely upon the Degree of Inflammation or the Time from Onset?新冠病毒病免疫抑制治疗的起始应取决于炎症程度还是发病时间？
Medicina (Kaunas). 2025 Jan 27;61(2):233. doi: 10.3390/medicina61020233.
2
Effect of methylprednisolone in reducing severe COVID-19 and mortality in high-risk patients: A retrospective study.甲泼尼龙对降低高危患者严重新型冠状病毒肺炎及死亡率的影响：一项回顾性研究。
SAGE Open Med. 2024 Sep 9;12:20503121241276683. doi: 10.1177/20503121241276683. eCollection 2024.
3
Impact of corticosteroids on initiation and half-year durability of humoral response in COVID-19 survivors.皮质类固醇对新冠病毒疾病幸存者体液免疫反应启动及半年持续性的影响
Chin Med J Pulm Crit Care Med. 2024 Mar 15;2(1):48-55. doi: 10.1016/j.pccm.2024.02.005. eCollection 2024 Mar.
4
Clinical Characteristics of Hospitalized Patients With COVID-19 and Their Association With the Progression to Critical Illness and Death: A Single-Center Retrospective Study From Northwestern Mexico.墨西哥西北部单中心回顾性研究：COVID-19 住院患者的临床特征及其与进展为重症和死亡的关系。
Clin Respir J. 2024 Jul;18(7):e13813. doi: 10.1111/crj.13813.
5
Steroid initiation timing and outcome of coronavirus disease 2019 patients: A multicenter, retrospective, observational study.类固醇起始时机与 COVID-19 患者结局的关系：一项多中心、回顾性、观察性研究。
Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231216314. doi: 10.1177/03946320231216314.
6
Efficacy and Safety Comparison of Two Different Doses of Dexamethasone in Hospitalized Patients with COVID-19: A Randomized Clinical Trial.两种不同剂量地塞米松对 COVID-19 住院患者的疗效与安全性比较：一项随机临床试验
J Res Pharm Pract. 2023 Aug 29;11(4):136-143. doi: 10.4103/jrpp.jrpp_42_22. eCollection 2022 Oct-Dec.
7
Steroid in the Treatment of Outpatient COVID-19: A Multicenter Randomized Controlled Trial.类固醇治疗门诊COVID-19：一项多中心随机对照试验。
Adv Biomed Res. 2023 May 15;12:122. doi: 10.4103/abr.abr_72_22. eCollection 2023.
8
Special Issue: "Respiratory Disease in the COVID-19 Era".特刊：“新冠时代的呼吸疾病”。
Medicina (Kaunas). 2023 May 5;59(5):886. doi: 10.3390/medicina59050886.
9
Extended Multicriteria Group Decision Making with a Novel Aggregation Operator for Emergency Material Supplier Selection.基于新型聚合算子的扩展多准则群体决策在应急物资供应商选择中的应用
Entropy (Basel). 2023 Apr 21;25(4):702. doi: 10.3390/e25040702.
10
Factors associated with prolonged viral shedding in older patients infected with Omicron BA.2.2.与感染奥密克戎 BA.2.2 的老年患者病毒持续排出相关的因素。
Front Public Health. 2023 Jan 12;10:1087800. doi: 10.3389/fpubh.2022.1087800. eCollection 2022.
本文引用的文献
1
Clinical progression of patients with COVID-19 in Shanghai, China.中国上海 COVID-19 患者的临床进展。
J Infect. 2020 May;80(5):e1-e6. doi: 10.1016/j.jinf.2020.03.004. Epub 2020 Mar 19.
2
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
3
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome.糖皮质激素治疗中东呼吸综合征危重症患者。
Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767. doi: 10.1164/rccm.201706-1172OC.
4
Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia.甲型H7N9流感病毒性肺炎成人患者的辅助性皮质类固醇治疗
Crit Care Med. 2016 Jun;44(6):e318-28. doi: 10.1097/CCM.0000000000001616.
5
Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients.早期皮质类固醇治疗对成年患者血浆中严重急性呼吸综合征相关冠状病毒RNA浓度的影响。
J Clin Virol. 2004 Dec;31(4):304-9. doi: 10.1016/j.jcv.2004.07.006.
Zotero 插件